{
    "id": 27077,
    "fullName": "TP53 H214R",
    "impact": "missense",
    "proteinEffect": "gain of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "TP53 H214R lies within the DNA-binding domain of the Tp53 protein (PMID: 15510160). H214R results in increased IL-6 expression and colony formation compared to wild-type Tp53 in cell culture (PMID: 11920959), and is therefore predicted to confer a gain of function to Tp53.",
            "references": [
                {
                    "id": 2466,
                    "pubMedId": 11920959,
                    "title": "Complex functions of mutant p53 alleles from human prostate cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/11920959"
                },
                {
                    "id": 5145,
                    "pubMedId": 15510160,
                    "title": "Post-translational modification of p53 in tumorigenesis.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/15510160"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 7157,
        "geneSymbol": "TP53",
        "terms": [
            "TP53",
            "BCC7",
            "BMFS5",
            "LFS1",
            "P53",
            "TRP53"
        ]
    },
    "variant": "H214R",
    "createDate": "10/05/2017",
    "updateDate": "08/01/2019",
    "referenceTranscriptCoordinates": {
        "id": 94502,
        "transcript": "NM_000546",
        "gDna": "chr17:g.7674890T>C",
        "cDna": "c.641A>G",
        "protein": "p.H214R",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 16191,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, combination Tafinlar (dabrafinib) and Mekinist (trametinib) therapy in a patient with Platinol (cisplatin)-resistant metastatic neuroendocrine carcinoma of the colon harboring BRAF V600E and TP53 H214R mutations and amplifications of FLT3 and CDK8 resulted in decreased disease burden with a clinical benefit for 5 months before disease progression (PMID: 30181415).",
            "molecularProfile": {
                "id": 31514,
                "profileName": "BRAF V600E CDK8 amp FLT3 amp TP53 H214R"
            },
            "therapy": {
                "id": 1066,
                "therapyName": "Dabrafenib + Trametinib",
                "synonyms": null
            },
            "indication": {
                "id": 4118,
                "name": "colon neuroendocrine neoplasm",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 14304,
                    "pubMedId": 30181415,
                    "title": "Targeting BRAF Mutations in High-Grade Neuroendocrine Carcinoma of the Colon.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30181415"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 16192,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, a patient with Platinol (cisplatin)-resistant metastatic neuroendocrine carcinoma of the colon harboring BRAF V600E and TP53 H214R mutations and amplifications of FLT3 and CDK8 who had an initial response to combination Tafinlar (dabrafinib) and Mekinist (trametinib) therapy was found to have acquired an ARID1B Q123* mutation upon disease progression (PMID: 30181415).",
            "molecularProfile": {
                "id": 31515,
                "profileName": "ARID1B Q123* BRAF V600E CDK8 amp FLT3 amp TP53 H214R"
            },
            "therapy": {
                "id": 1066,
                "therapyName": "Dabrafenib + Trametinib",
                "synonyms": null
            },
            "indication": {
                "id": 4118,
                "name": "colon neuroendocrine neoplasm",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 14304,
                    "pubMedId": 30181415,
                    "title": "Targeting BRAF Mutations in High-Grade Neuroendocrine Carcinoma of the Colon.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30181415"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 28461,
            "profileName": "TP53 H214R",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 31514,
            "profileName": "BRAF V600E CDK8 amp FLT3 amp TP53 H214R",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 31515,
            "profileName": "ARID1B Q123* BRAF V600E CDK8 amp FLT3 amp TP53 H214R",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 94502,
            "transcript": "NM_000546",
            "gDna": "chr17:g.7674890T>C",
            "cDna": "c.641A>G",
            "protein": "p.H214R",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 94501,
            "transcript": "NM_001126112",
            "gDna": "chr17:g.7674890T>C",
            "cDna": "c.641A>G",
            "protein": "p.H214R",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 94503,
            "transcript": "NM_001126113",
            "gDna": "chr17:g.7674890T>C",
            "cDna": "c.641A>G",
            "protein": "p.H214R",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 94504,
            "transcript": "NM_001126114",
            "gDna": "chr17:g.7674890T>C",
            "cDna": "c.641A>G",
            "protein": "p.H214R",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}